This content is from:Premium Elliott’s CDK Battle Is One of Many The aggressive hedge fund firm has notched some victories against one of many activist targets. ByStephen Taub June 10, 2016
This content is from:Premium The Hedge Funds Poised to Profit From a Drug Maker’s IPO At least four hedge funds own nearly half of the shares of the latest biopharma company planning to go public. BySteve Taub August 22, 2019
This content is from:Premium Tiger Bloc’s Biggest Holdings: Actavis, CDK and JD.com Group of 50 Tiger Cubs, Seeds and Grandcubs often invest in many of the same stocks. The big winner: Irish drugmaker Actavis. ByStephen Taub June 04, 2015
This content is from:365亚博 The Morning Brief: Ackman’s Pershing Square Dumps Canadian Pacific Stake ByAmanda Cantrell August 05, 2016
This content is from:365亚博 The Morning Brief: Elliott Discloses CDK Global Stake ByStephen Taub May 13, 2015
This content is from:365亚博 The Morning Brief: Scandal and the Law Dog Visium and Platinum ByStephen Taub June 24, 2016
